Axcelis Technologies Inc (ACLS)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Axcelis Technologies Inc.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 23 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 130.40 $ — 51% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/03/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
This stock currently pays no dividend.
Quality & Screener
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Growth Score
4 of 10 Weak growthTen checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years -3.0% failed
- More than 10% revenue growth is expected for the coming year 9.6% failed
- Share count grows by less than 3% a year -1.9% passed
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") -4.8% failed
- Gross margin at 40% or higher and without meaningful erosion 44.9% passed
- Goodwill from acquisitions does not grow faster than revenue 0.0% passed
- Net debt below twice EBITDA 332 m net cash passed
- Operating cash flow covers the profits of the last three years -152 m failed
- Return on capital at 15% or higher, or up versus two years ago 10.3% failed
- Insiders hold at least 10% or are net buyers 0.7% failed
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Analysts & Price Target
The price target sits 30.1% above the current price.
- Consensus
- Sell
- Analyst Ratings
- 5
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 3.83 | 3.68 – 4.00 | 844 | -21.4% | 5 |
| 12/31/2027 | 4.85 | 4.10 – 5.76 | 925 | 26.5% | 5 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Next Reporting Date
- Expected Earnings per Share
- 0.69 $
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | 1.54 | -28.60 | 252 | -18.70 | 19.80 | 13 | 8 |
| 2025: Q1 | 0.88 | -43.60 | 193 | -23.70 | 14.80 | 40 | 35 |
| 2025: Q2 | 0.98 | -37.00 | 195 | -24.20 | 16.10 | 40 | 38 |
| 2025: Q3 | 0.83 | -44.40 | 214 | -16.70 | 12.20 | 45 | 43 |
| 2025: Q4 | 1.10 | -28.30 | 238 | -5.60 | 14.40 | -7 | -9 |
| 2026: Q1 | 0.30 | -66.30 | 199 | 3.30 | 4.60 | 18 | 16 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2016 | 267 | 17 | 11 | 0.36 | -9 | 201 | 302 |
| 2017 | 411 | 48 | 127 | 3.80 | 56 | 354 | 488 |
| 2018 | 443 | 60 | 46 | 1.35 | 47 | 408 | 548 |
| 2019 | 343 | 24 | 17 | 0.50 | -14 | 419 | 548 |
| 2020 | 475 | 58 | 50 | 1.46 | 70 | 482 | 625 |
| 2021 | 662 | 127 | 99 | 2.88 | 150 | 539 | 753 |
| 2022 | 920 | 212 | 183 | 5.46 | 216 | 667 | 1,014 |
| 2023 | 1,131 | 266 | 246 | 7.43 | 157 | 865 | 1,282 |
| 2024 | 1,018 | 211 | 201 | 6.15 | 141 | 1,013 | 1,349 |
| 2025 | 839 | 119 | 120 | 3.80 | 118 | 1,035 | 1,361 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
About the Company
Axcelis Technologies, Inc. entwirft, fertigt und wartet Ionenimplantations- und andere Bearbeitungsanlagen für die Herstellung von Halbleiterchips in den USA, Europa und im asiatisch-pazifischen Raum.
| CEO Insider Trades (12 Mo.) | selling own stock |
|---|---|
| Employees | 1,465 |
| Headquarters | Beverly, MA |
| Address | 108 Cherry Hill Drive, 01915-1088 Beverly, United States |
| Phone | 978 787 4000 |
| Website | axcelis.com |
| IPO Date | 11. Jul 2000 |
| ISIN | US0545402085 |
| Stock Split | 1:4 on 07/01/2016 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Russell J. Low Ph.D. | CEO, President & Director | 1971 |
| Eileen J. Evans Esq. | Executive VP of Human Resources and Legal, General Counsel & Secretary | 1968 |
| Gregory F. Redinbo Ph.D. | Executive Vice President of Marketing & Applications | 1965 |
| Gerald M. Blumenstock | Executive Vice President of Research, Development & Engineering | 1969 |
| Christopher J. Tatnall Ph.D. | Executive Vice President of Global Customer Operations | 1973 |
| David Ryzhik | Interim CFO & Senior VP of Investor Relations and Corporate Strategy | – |
| Robert J. Mahoney | Executive Vice President of Global Operations | 1962 |
| Todd Sutton | VP of Corporate Controller | – |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 15. Jul 2026 | Ryzhik David | SVP Interim CFO | Other | 94 | 145.01 | 13,631 |
| 15. Jul 2026 | Ryzhik David | SVP Interim CFO | Other | 127 | 145.01 | 18,416 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.